Product category:
Laboratory and scientific databases
News Release from: Inforsense
Edited by the Laboratorytalk Editorial
Team on 10 February 2003
Licence agreement for discovery platform
InforSense to supply advanced cheminformatics environment (data mining, analysis and workflow management software) to Boehringer Ingelheim Pharma
InforSense, the provider of discovery informatics platforms, has announced a licensing agreement with Boehringer Ingelheim Pharma for InforSense's enterprise discovery platform, Kensington Discovery Edition, and associated consulting services InforSense's data mining, analysis and workflow management software will provide a unified multi-user client-server environment to accelerate lead generation and optimisation
This article was originally published on Laboratorytalk on 3 May 2002 at 8.00am (UK)
Related stories
Industrial scale discovery management
Upgraded softwatre package addresses needs of life sciences and research organisations requiring a unified platform for data integration, data analysis and discovery process design
Informatics system wins prestigious award
Researchers demonstrated their innovative ability to analyse large-scale genomic data in real time using intercontinental distributed computing resources
At Boehringer Ingelheim, Kensington Discovery Edition will enable integration of multiple hardware platforms, cheminformatics database systems, and computational tools.
Solutions, tailored to Boehringer Ingelheim's needs and exploiting leading third-party software components will feature powerful, customisable web applications and flexible reporting capabilities to drive discovery decisions.
Unlike other data-pipelining approaches, Kensington Discovery Edition will offer a highly flexible environment for developing and modifying information processing and knowledge discovery workflows.
Third party solutions and databases can be easily integrated as nodes in the workflows.
Additionally, there is scope for specialists to build complex applications collaboratively, including developing standard processes, and to deploy them effectively as interactive end-user applications.
Commenting on the agreement, Yike Guo, CEO of InforSense, said: "We are delighted to be working with Boehringer Ingelheim to provide such powerful cheminformatics capabilities.
Our Kensington technology offers a highly flexible environment for bringing together best-of-breed components to create and deliver advanced decision-support capabilities to the desktop." "Kensington Discovery Edition's proven multi-platform integration will enable us to exploit our existing informatics investment and provide a highly extensible discovery environment for the future", added Herbert Köppen, head of chemoinformatics of Boehringer Ingelheim.
• Inforsense: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
